Similar Articles
1311
Signaling pathway/molecular targets and new targeted agents under development in hepatocellular carcinoma
1312
Expression characteristics and diagnostic value of annexin A2 in hepatocellular carcinoma
1313
Evaluation of sorafenib for hepatocellular carcinoma by contrast-enhanced ultrasonography: A pilot study
1314
Axl glycosylation mediates tumor cell proliferation, invasion and lymphatic metastasis in murine hepatocellular carcinoma
1315
Identification of deregulated miRNAs and their targets in hepatitis B virus-associated hepatocellular carcinoma
1316
Natural history of untreatable hepatocellular carcinoma: A retrospective cohort study
1317
High-risk esophageal varices in patients treated with locoregional therapy for hepatocellular carcinoma: Assessment with liver computed tomography
1318
Endothelial precursor cells promote angiogenesis in hepatocellular carcinoma
1319
Prognosis of hepatocellular carcinoma expressing cytokeratin 19: Comparison with other liver cancers
1320
Hyperthermia inhibits hypoxia-induced epithelial-mesenchymal transition in HepG2 hepatocellular carcinoma cells
Page 132 of 175 ( 1742 items )
<<
1
...
128
129
130
131
132
133
134
135
...
175
>>
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA